Citation Impact
Citing Papers
A "Silent" Polymorphism in the MDR 1 Gene Changes Substrate Specificity
2006 StandoutScience
EGFR Mutations in Lung Cancer: Correlation with Clinical Response to Gefitinib Therapy
2004 StandoutScience
Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult
2002 Standout
Multidrug resistance in cancer: role of ATP–dependent transporters
2002 Standout
Pharmacokinetic Drug Interactions of Vinca Alkaloids: Summary of Case Reports
1998
Myeloid-derived suppressor cells coming of age
2018 Standout
Intracavitary chemotherapy with thiotepa in malignant pericardial effusions: an active and well-tolerated regimen.
1998
Diurnal Cortisol Rhythm as a Predictor of Breast Cancer Survival
2000 Standout
Modulatory effect of prolactin on the resting and mitogen-induced activity of T, B, and NK lymphocytes
1992
Drugs as CYP3A Probes, Inducers, and Inhibitors
2007
Homozygous disruption of the murine MDR2 P-glycoprotein gene leads to a complete absence of phospholipid from bile and to liver disease
1993 Standout
Epidermal growth factor receptor mutations in lung cancer
2007 Standout
Principles of nanoparticle design for overcoming biological barriers to drug delivery
2015 Standout
Smoldering and polarized inflammation in the initiation and promotion of malignant disease
2005 Standout
Cancer drug resistance: an evolving paradigm
2013 Standout
Hyaluronan: from extracellular glue to pericellular cue
2004 Standout
Nanoparticle therapeutics: an emerging treatment modality for cancer
2008 Standout
Multidrug resistance (mdr) genes in human cancer
1991
Cremophor EL
2001 Standout
Developmental and maturational changes in human blood lymphocyte subpopulations
1992
Does prolactin play a role in skin biology and pathology?
1991
The CD4/CD8 ratio in BAL fluid is highly variable in sarcoidosis
1997
Inhibition of βARK1 Restores Impaired Biochemical β-Adrenergic Receptor Responsiveness but does not Rescue CREBA133 Induced Cardiomyopathy
2002 StandoutNobel
Nanocarriers as an emerging platform for cancer therapy
2007 Standout
Brucellosis
2005 Standout
Neoplastic pericardial effusion. Efficacy and safety of intrapericardial treatment with cisplatin
2002
Malignancy-related pericardial effusion. 127 cases from the roswell park cancer institute
1995
The clinical pharmacology and use of antimicrotubule agents in cancer chemotherapeutics
1991
Review Environmental factors and primary T‐cell sensitisation to inhalant allergens in infancy: reappraisal of the role of infections and air pollution
1995
Biology of Natural Killer Cells
1989 Standout
Acute Stressors and Cortisol Responses: A Theoretical Integration and Synthesis of Laboratory Research.
2004 Standout
Targeting multidrug resistance in cancer
2006 Standout
Allergic Rhinitis and Its Impact on Asthma
2001 Standout
Lymphocytes bearing the γδ T cell receptor in acute Brucella melitensis infection
1993
The Role of Myeloid-Derived Suppressor Cells in Immune Ontogeny
2014
A simple controlled‐rate freezing method without a rate‐controlled programmed freezer provides optimal conditions for both large‐scale and small‐scale cryopreservation of umbilical cord blood cells
2003 StandoutNobel
Hyporesponsiveness of “naive” (CD45RA+) human T cells to multiple receptor‐mediated stimuli but augmentation of responses by co‐stimuli
1990
The role of human cytochrome P450 enzymes in the metabolism of anticancer agents: implications for drug interactions.
1995
Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression
2001 Standout
Mesoporous Silica Nanoparticles: Synthesis, Biocompatibility and Drug Delivery
2012 Standout
Amino acids and immune function
2007 Standout
Sarcoidosis
1997 Standout
Pharmacological considerations in the modulation of multidrug resistance
1996
Classification of the cardiomyopathies: a position statement from the european society of cardiology working group on myocardial and pericardial diseases
2007 Standout
Cirrhosis-associated immune dysfunction: Distinctive features and clinical relevance
2014 Standout
Innate immunity of the newborn: basic mechanisms and clinical correlates
2007 Standout
Paul Ehrlich's magic bullet concept: 100 years of progress
2008 Standout
Cisplatin in cancer therapy: Molecular mechanisms of action
2014 Standout
Immunotherapy of Diffuse Gliomas: Biological Background, Current Status and Future Developments
2009 Standout
Oral verapamil with chemotherapy for advanced non-small cell lung cancer: a randomised study
1993
Cytochrome P450 enzymes in drug metabolism: Regulation of gene expression, enzyme activities, and impact of genetic variation
2013 Standout
ENHANCED VINCRISTINE NEUROTOXICITY FROM DRUG INTERACTIONS: Case Report and Review of Literature
2001
Clinical relevance of P-glycoprotein expression in haematological malignancies
1994
Idiopathic Dilated Cardiomyopathy
1994
Topoisomerase I inhibitors: camptothecins and beyond
2006 Standout
Elevated basal cortisol levels and attenuated acth and cortisol responses to a behavioral challenge in women with metastatic breast cancer
1996
Strategies for reversing drug resistance
2003
Increased secretion of tumor necrosis factor-alpha, interleukin-1-beta, and interleukin-6 by alveolar macrophages from patients with sarcoidosis
1993
An Official American Thoracic Society Clinical Practice Guideline: The Clinical Utility of Bronchoalveolar Lavage Cellular Analysis in Interstitial Lung Disease
2012 Standout
Biochemical Modulation of Cisplatin Mechanisms of Action: Enhancement of Antitumor Activity and Circumvention of Drug Resistance
2003 Standout
Tumour stem cells and drug resistance
2005 Standout
Therapeutic Nanoparticles for Drug Delivery in Cancer
2008 Standout
Hypothalamic control of certain aspects of natural immunity in the mouse.
1987
Studies of human cord blood dendritic cells: evidence for functional immaturity
1994
Differentiation of T cell lymphokine gene expression: the in vitro acquisition of T cell memory.
1991
The Roles of Prolactin, Growth Hormone, Insulin-Like Growth Factor-I, and Thyroid Hormones in Lymphocyte Development and Function: Insights from Genetic Models of Hormone and Hormone Receptor Deficiency*
2000
Prolactin (PRL) and Its Receptor: Actions, Signal Transduction Pathways and Phenotypes Observed in PRL Receptor Knockout Mice
1998 Standout
Guidelines on the Diagnosis and Management of Pericardial Diseases Executive SummaryThe Task Force on the Diagnosis and Management of Pericardial Diseases of the European Society of Cardiology
2004 Standout
Chemotherapy of advanced non-small cell lung cancer
1999
Evolution of the immune system in humans from infancy to old age
2015 Standout
Activation and differentiation requirements of primary T cells in vitro.
1993 StandoutNobel
Twenty-Two Years of Phase III Trials for Patients With Advanced Non–Small-Cell Lung Cancer: Sobering Results
2001
Nanotechnology for Multimodal Synergistic Cancer Therapy
2017 Standout
Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America
2016 Standout
Loss of the CD5+ and CD45RAhi B cell subsets in alcoholics
1996
The PPARs: From Orphan Receptors to Drug Discovery
2000 Standout
Antibodies to the ADP/ATP carrier, an autoantigen in myocarditis and dilated cardiomyopathy, penetrate into myocardial cells and disturb energy metabolism in vivo.
1989
Mononuclear lymphoid populations infiltrating the microenvironment of primary CNS tumors
1984
Controls of Hair Follicle Cycling
2001 Standout
Human naive and memory T cells
1988
T gamma-lymphoproliferative disease and related disorders in humans and experimental animals: a review of the clinical, cellular, and functional characteristics
1984
Update: Clinically Significant Cytochrome P‐450 Drug Interactions
1998
Autoimmune Dilated Cardiomyopathy in PD-1 Receptor-Deficient Mice
2001 StandoutScienceNobel
Antigen-independent activation of naive and memory resting T cells by a cytokine combination.
1994 Standout
Placental and/or Umbilical Cord Blood: An Alternative Source of Hematopoietic Stem Cells for Transplantation
1997
Drug Resistance in Leishmaniasis
2006 Standout
Works of P Rambotti being referenced
Phenotypic and functional abnormalities of T lymphocytes in pathological hyperprolactinemia
1987
Activation of cord T lymphocytes
1990
Defective natural killer cell activity in puerperal hyperprolactinemia
1989
Helper Inducer T Cells in the Lungs of Sarcoidosis Patients
1989
Thymic hormone modulation of CD38 (T10) antigen on human cord blood lymphocytes
1987
Intrapericardial tetracycline sclerosis in the treatment of malignant pericardial effusion: an analysis of thirty-three cases.
1984
Reduced number of natural killer cells in patients with pathological hyperprolactinemia.
1986
Immunoregulatory T cells in alcoholic liver disease: phenotypical dissection of circulating Leu3+/T4+ inducer T-lymphocytes.
1987
Pharmacokinetics of vincristine in cancer patients treated with nifedipine
1989
Phenotypic dissection of cord blood immunoregulatory T-cell subsets by using a two-color immunofluorescence study
1986
Single-agent and combination chemotherapy for extensive non-small cell carcinomas of the lung.
1981
Activation of cord T lymphocytes. I. Evidence for a defective T cell mitogenesis induced through the CD2 molecule.
1989
Combination cyclophosphamide, doxorubicin, and cisplatin (CAP) chemotherapy for extensive non-small cell carcinomas of the lung.
1982
Helper cell function of Leukemic Leu-2a+, histamine receptor+, T gamma lymphocytes.
1982
Immunologic studies of peripheral blood from patients with idiopathic dilated cardiomyopathy
1986
Immunological Studies in Patients with Alcoholic Liver Disease: Evidence for the in vivo Activation of Helper T Cells and of the Monocyte-Macrophage System
1986